The Venture Codex Logo

The Venture Codex

Cancer Research Horizons

2 Redman Place, London, England, E20 1JQ, United Kingdom

Overview

Develops and commercializes innovations in cancer research.

Founded

2002

Deals ยท 12mo

3

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A

Geographic focus

The Netherlands
United Kingdom
United States

Sector focus

Biotechnology
Clinical Trials
Health Diagnostics
Medical
...

Investment portfolio

11rounds
NAMEDATESIZE
52 North Health
Sep 2026Participated
$4 MOther Equity
Laigo Bio
Mar 2026Participated
$19 MSeed
Laigo Bio
Dec 2025Participated
$13 MSeed
Trogenix
Oct 2025Participated
$94 MSeries A
AiM Medical Robotics
Sep 2025Participated
$8 MSeries A
52 North Health
Dec 2024Participated
$6 MOther Equity
Infinitopes
May 2024Participated
$16 MSeed
Neobe Therapeutics
Mar 2024Participated
$2 MOther Equity
NK:IO
Jul 2023Led
$2 MOther Equity
BioCaptiva
Jun 2022Participated
$3 MSeed
Achilles Therapeutics
Nov 2016Led
$16 MOther Equity
52 North Health
Sep 2026Participated
$4 MOther Equity
Laigo Bio
Mar 2026Participated
$19 MSeed
Laigo Bio
Dec 2025Participated
$13 MSeed
Trogenix
Oct 2025Participated
$94 MSeries A
AiM Medical Robotics
Sep 2025Participated
$8 MSeries A
52 North Health
Dec 2024Participated
$6 MOther Equity
Infinitopes
May 2024Participated
$16 MSeed
Neobe Therapeutics
Mar 2024Participated
$2 MOther Equity
NK:IO
Jul 2023Led
$2 MOther Equity
BioCaptiva
Jun 2022Participated
$3 MSeed
Achilles Therapeutics
Nov 2016Led
$16 MOther Equity
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cancer Research Horizons: 11 funding rounds are recorded in the selected participation categories.All available history.
Cancer Research Horizons: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed04
Series A02
Other Equity23

Monthly Deal Activity

Cancer Research Horizons: 11 deals are recorded across 120 months.All available history.
Cancer Research Horizons: 11 deals are recorded across 120 months. All available history
MonthDeals
Nov '161
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '241
Apr '240
May '241
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '241
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '251
Nov '250
Dec '251
Jan '260
Feb '260
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

Cancer Research Horizons: Health & Life Sciences is the largest displayed sector by deal count (11 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cancer Research Horizons: Health & Life Sciences is the largest displayed sector by deal count (11 deals). All available history
SectorDeals
Health & Life Sciences11
AI & Machine Learning2
Hardware & Robotics1
Space & Frontier Tech1

Deal Size Distribution

Cancer Research Horizons: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cancer Research Horizons: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M2
$10M-$25M4
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cancer Research Horizons: Europe has the largest recorded deal count among the displayed regions (10 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Cancer Research Horizons: Europe has the largest recorded deal count among the displayed regions (10 deals). All available history
RegionDeals
Europe10
United States1
Cancer Research Horizons: 20 co-investors are shown, with Meltwind sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cancer Research Horizons: 20 co-investors are shown, with Meltwind sharing 3 recorded deals. All available history
Co-investorShared deals
Meltwind3
Angelini Ventures2
ArgoBio2
Curie Capital2
Eurazeo2
Innovate UK2
IQ Capital2
Kurma Partners2
Macmillan Cancer Support2
OKG Capital2
Oncode Oncology Bridge Fund2
ROM Utrecht Region2
1540 Ventures1
2048 Ventures1
Angel Star Ventures1
Archangels1
Biovance Capital1
Calculus Capital1
Cambridge Enterprise1
Cancer Research Institute1

Investment Strategy

Cancer Research Horizons: Led accounts for 18% and participating for 82% of round participation.All available history.
Cancer Research Horizons: Led accounts for 18% and participating for 82% of round participation. All available history
CategoryDeals (count)Share (%)
Led218%
Participating982%
Cancer Research Horizons: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Cancer Research Horizons: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Deborah Harland

Non Executive Director

Phil Masterson
Raj Mehta

Team Member